Items where authors include "Price, G."

Article

Bentham, R., Jones, T.P. orcid.org/0000-0003-2748-0780, Black, J.R.M. orcid.org/0000-0001-5598-7752 et al. (327 more authors) (2025) ImmuneLENS characterizes systemic immune dysregulation in aging and cancer. Nature Genetics, 57. pp. 694-705. ISSN 1061-4036

Biswas, D. orcid.org/0000-0001-9141-5188, Liu, Y.-H. orcid.org/0009-0001-1508-5276, Herrero, J. orcid.org/0000-0001-7313-717X et al. (267 more authors) (2025) Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma. Nature Cancer, 6. pp. 86-101. ISSN 2662-1347

Black, J.R.M. orcid.org/0000-0001-5598-7752, Bartha, G., Abbott, C.W. et al. (277 more authors) (2025) Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma. Nature Medicine, 31 (1). pp. 70-76. ISSN 1078-8956

Fornacon-Wood, I., Nuamek, T., Hudson, E.M. et al. (9 more authors) (2024) Analyzing patient-reported outcome data in oncology care. International Journal of Radiation Oncology • Biology • Physics. ISSN 0360-3016

Puttick, C. orcid.org/0009-0006-3022-8737, Jones, T.P. orcid.org/0000-0003-2748-0780, Leung, M.M. orcid.org/0000-0001-9555-1080 et al. (279 more authors) (2024) MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolution. Nature Genetics, 56. pp. 2121-2131. ISSN 1061-4036

Hobor, S., Al Bakir, M. orcid.org/0000-0002-0846-8332, Hiley, C.T. et al. (292 more authors) (2024) Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling. Nature Communications, 15. 4871. ISSN 2041-1723

Hynds, R.E. orcid.org/0000-0002-2170-8791, Huebner, A. orcid.org/0000-0001-8009-4999, Pearce, D.R. orcid.org/0000-0001-8443-2924 et al. (274 more authors) (2024) Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models. Nature Communications, 15 (1). 4653. ISSN 2041-1723

Kapadi, A., Price, G., Faivre-Finn, C. et al. (8 more authors) (2024) Feasibility of implementing a rapid-learning methodology to inform radiotherapy treatments: key professional stakeholders’ views. BMJ Oncology, 3 (1). e000226. ISSN 2752-7948

Pan, X., AbdulJabbar, K. orcid.org/0000-0002-4411-4435, Coelho-Lima, J. et al. (276 more authors) (2024) The artificial intelligence-based model ANORAK improves histopathological grading of lung adenocarcinoma. Nature Cancer, 5 (2). pp. 347-363. ISSN 2662-1347

Fornacon-Wood, I., Banfill, K., Ahmad, S. et al. (22 more authors) (2023) Impact of the COVID-19 pandemic on outcomes for patients with lung cancer receiving curative-intent radiotherapy in the UK. Clinical Oncology, 35 (10). e593-e600. ISSN 0936-6555

Ng, K.W., Boumelha, J., Enfield, K.S.S. orcid.org/0000-0002-4551-6073 et al. (328 more authors) (2023) Antibodies against endogenous retroviruses promote lung cancer immunotherapy. Nature, 616. pp. 563-573. ISSN 0028-0836

Martínez-Ruiz, C. orcid.org/0000-0002-4817-0565, Black, J.R.M., Puttick, C. et al. (294 more authors) (2023) Genomic–transcriptomic evolution in lung cancer and metastasis. Nature, 616. pp. 543-552. ISSN 0028-0836

Abbosh, C. orcid.org/0000-0002-8983-1382, Frankell, A.M. orcid.org/0000-0002-0341-7878, Harrison, T. et al. (303 more authors) (2023) Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA. Nature, 616 (7957). pp. 553-562. ISSN 0028-0836

Frankell, A.M. orcid.org/0000-0002-0341-7878, Dietzen, M. orcid.org/0000-0002-6853-7563, Al Bakir, M. orcid.org/0000-0002-0846-8332 et al. (284 more authors) (2023) The evolution of lung cancer and impact of subclonal selection in TRACERx. Nature, 616. pp. 525-533. ISSN 0028-0836

Al Bakir, M. orcid.org/0000-0002-0846-8332, Huebner, A. orcid.org/0000-0001-8009-4999, Martínez-Ruiz, C. orcid.org/0000-0002-4817-0565 et al. (283 more authors) (2023) The evolution of non-small cell lung cancer metastases in TRACERx. Nature, 616. pp. 534-542. ISSN 0028-0836

Hill, W., Lim, E.L., Weeden, C.E. et al. (323 more authors) (2023) Lung adenocarcinoma promotion by air pollutants. Nature, 616 (7955). pp. 159-167. ISSN 0028-0836

Al-Sawaf, O. orcid.org/0000-0001-9895-0570, Weiss, J., Skrzypski, M. et al. (302 more authors) (2023) Body composition and lung cancer-associated cachexia in TRACERx. Nature Medicine, 29 (4). pp. 846-858. ISSN 1078-8956

Karasaki, T. orcid.org/0000-0001-6863-2360, Moore, D.A. orcid.org/0000-0002-6296-1312, Veeriah, S. et al. (288 more authors) (2023) Evolutionary characterization of lung adenocarcinoma morphology in TRACERx. Nature Medicine, 29 (4). pp. 833-845. ISSN 1078-8956

Sadlon, A., Takousis, P., Evangelou, E. et al. (6 more authors) (2023) Association of blood microRNA expression and polymorphisms with cognitive and biomarker changes in older adults. The Journal Of Prevention of Alzheimer's Disease, 11 (1). pp. 230-240. ISSN 2274-5807

Wu, Y. orcid.org/0000-0003-4080-3935, Biswas, D. orcid.org/0000-0001-9141-5188, Usaite, I. et al. (302 more authors) (2022) A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer. Nature Cancer, 3. pp. 696-709. ISSN 2662-1347

Banfill, K., Croxford, W., Fornacon-Wood, I. et al. (22 more authors) (2022) Changes in the management of patients having radical radiotherapy for lung cancer during the first wave of the COVID-19 pandemic in the UK. Clinical Oncology, 34 (1). pp. 19-27. ISSN 0936-6555

Fennell, D.A., Ewings, S., Ottensmeier, C. et al. (36 more authors) (2021) Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial. The Lancet Oncology, 22 (11). pp. 1530-1540. ISSN 1470-2045

Ball, H.A., McWhirter, L., Ballard, C. et al. (20 more authors) (2021) Reply : Functional cognitive disorder : dementia's blind spot. Brain, 144 (9). e73. ISSN 0006-8950

Ball, H.A., McWhirter, L., Ballard, C. et al. (22 more authors) (2020) Functional cognitive disorder : dementia’s blind spot. Brain, 143 (10). pp. 2895-2903. ISSN 0006-8950

Peters, S., Danson, S. orcid.org/0000-0002-3593-2890, Hasan, B. et al. (35 more authors) (2020) A randomized open-label phase III trial evaluating the addition of denosumab to standard first-line treatment in advanced NSCLC : the European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR trial. Journal of Thoracic Oncology, 15 (10). pp. 1647-1656. ISSN 1556-0864

Monograph

Petrillo, M., Bennett, M.R. orcid.org/0000-0002-9523-6053 and Price, G. (2022) Cycles of caring: transitions in and out of unpaid care. Report. Carers UK , London.

Conference or Workshop Item

Swinton, M., Portner, R., Brooks, L. et al. (8 more authors) (2023) MR Delta Radiomics during Radiotherapy to Prostate Cancer: Does Dose per Fraction Matter? In: ESTRO 2023, 13-16 May 2023, Vienna, Austria.

Portner, R., McWilliam, A., Zhong, J. et al. (16 more authors) (2022) Prostate Magnetic Resonance Imaging Delta-Radiomics during Image-Guided Conventional Fractionation and Stereotactic Ablative Radiotherapy. In: UNSPECIFIED.